Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine

J Neurochem. 2005 Sep;94(5):1402-10. doi: 10.1111/j.1471-4159.2005.03289.x. Epub 2005 Jun 30.

Abstract

Insulin affects brain reward pathways and there is converging evidence that this occurs through insulin regulation of the dopamine (DA) transporter (DAT). In rats made hypoinsulinemic by fasting, synaptosomal DA uptake is reduced. Interestingly, [3H]DA uptake is increased in hypoinsulinemic rats with a history of amphetamine self-administration. The possibility that amphetamine and insulin act in concert to regulate DAT activity prompted this study. Here we show that [3H]DA uptake, measured in vitro and clearance of exogenously applied DA in vivo, is significantly reduced in rats made hypoinsulinemic by a single injection of streptozotocin. Strikingly, amphetamine (1.78 mg/kg, given every other day for 8 days) restored DA clearance in streptozotocin-treated rats but was without effect on DA clearance in saline-treated rats. Basal locomotor activity of streptozotocin-treated rats was lower compared to control rats; however, in streptozotocin-treated rats, hyperlocomotion induced by amphetamine increased over successive amphetamine injections. In saline-treated rats the locomotor stimulant effect of amphetamine remained stable across the four amphetamine injections. These results provide exciting new evidence that actions of amphetamine on DA neurotransmission are insulin-dependent and further suggest that exposure to amphetamine may cause long-lasting changes in DAT function.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amphetamine / administration & dosage
  • Amphetamine / pharmacology*
  • Animals
  • Body Weight
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / physiopathology*
  • Dopamine / metabolism*
  • Dopamine / pharmacokinetics
  • Dopamine Agents / administration & dosage
  • Dopamine Agents / pharmacology*
  • Dopamine Plasma Membrane Transport Proteins
  • Drug Administration Schedule
  • Insulin / blood*
  • Male
  • Membrane Glycoproteins / drug effects
  • Membrane Glycoproteins / metabolism*
  • Membrane Transport Proteins / drug effects
  • Membrane Transport Proteins / metabolism*
  • Motor Activity / drug effects*
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / metabolism*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Dopamine Agents
  • Dopamine Plasma Membrane Transport Proteins
  • Insulin
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Slc6a3 protein, rat
  • Amphetamine
  • Dopamine